None listed
Conditions
Interventions
Case series:Venus TAVR System
Sponsors
Qilu Hospital, Shandong University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients who have received or will receive Venus TAVR System to treat aortic valve disease; 2.Willing to sign the ICF of the study and complete the follow-up according to the study requirements.
Exclusion criteria
Exclusion criteria: 1. Not willing to sign the informed consent form; 2. Unable to comply with the study protocol and complete clinical follow-up for various reasons; 3. The investigator evaluated that the patient was not suitable for transcatheter aortic valve replacement.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All cause mortality;Function of bioprosthetic valves; | — |
Countries
China
Contacts
Public ContactFangni Wang
Venus Medtech (Hangzhou) Inc.
Outcome results
None listed